Form D · Biotechnology
REGENESIS BIOMEDICAL INC
Scottsdale, AZ · CIK 0001172973
Offering snapshot reported Jun 21, 2011 · SEC filing
- Reported sold
- $5.2M Indefinite offering
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $2.36K Reported outside-investor minimum
- First sale
- Jun 2, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2011 | Initial | $5,202,364 | No comparison | 9 | SEC filing |
| May 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 21, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 21, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-161541
Source: Form D, filed Jun 21, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jack Ahrens | Director |
| Dennis Genge | Executive |
| Tom Greer | Director |
| Chuck Lunden | Director |
| Henry Newman | Director |
| Virginia Rybski | Director, Executive |
| Peter Sheehan | Director |
| John Voris | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1435 North Hayden Road
Scottsdale, AZ, 85257-3773
Scottsdale, AZ, 85257-3773